KL003 cell injection Drug Product
IIT2023021
Unknown gene_therapy active
Quick answer
KL003 cell injection Drug Product for Transfusion-dependent Beta-Thalassemia is a Unknown program (gene_therapy) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Indication
- Transfusion-dependent Beta-Thalassemia
- Phase
- Unknown
- Modality
- gene_therapy
- Status
- active